Compare Hims and Hers Health Inc (HIMS) vs Nu Holdings Ltd (NU) Price & Performance

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.

The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.

NU stock trades at $14.125, up 3.94% today, with a bearish technical signal but strong fundamentals including 26.72% net income margin and 30.04% ROE. Recent earnings show mixed results with two misses, but revenue growth accelerated from $3.0B in 2022 to $10.63B in 2025. The company secured banking approval in Mexico, expanding its Latin American footprint to 15 million customers as of July 2026 (Bloomberg, 2026-07-15).

Outlook remains positive with a $14.98 consensus price target (54.55% buy ratings), though risks include high P/E of 20.96 and debt-to-asset ratio volatility. Growth catalysts from Mexico expansion and digital banking dominance support long-term potential, but near-term headwinds from earnings misses and competitive pressures warrant caution.